U.S. Markets open in 6 hrs 48 mins

Glaukos Corporation (GKOS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
89.02-7.06 (-7.35%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close96.08
Open95.85
Bid0.00 x 800
Ask100.00 x 1100
Day's Range88.20 - 96.46
52 Week Range23.31 - 99.00
Volume444,993
Avg. Volume433,315
Market Cap4.028B
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-2.70
Earnings DateMay 05, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est87.89
  • Business Wire

    Glaukos Announces Participation in Oppenheimer Healthcare Conference

    Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the Oppenheimer 31st Annual Healthcare Conference on Tuesday, March 16, 2021, at 3:10 p.m. EDT.

  • Business Wire

    Glaukos Appoints Denice Torres and Dr. Leana Wen to its Board of Directors

    Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the appointment of Denice Torres and Dr. Leana Wen to its Board of Directors, effective today. With the addition of these two directors, Glaukos’ Board of Directors will be comprised of nine directors, eight of whom are independent.

  • Glaukos Corp (GKOS) Q4 2020 Earnings Call Transcript
    Motley Fool

    Glaukos Corp (GKOS) Q4 2020 Earnings Call Transcript

    GKOS earnings call for the period ending December 31, 2020.